On the formation of [H3C-S-S-CH3]+* ions from the bis(dimethylthio)mercury molecular ion

Al3+ enhanced room temperature phosphorescence of Pd-porphyrin resided in hybrid supramolecular gels and used for detection of trace Hg2+ ions

Micelle-hybridized supramolecular hydrogels were constructed through the self-assembly of gelator N,N-dibenzoyl-L-cystine (DBC) and micelles formed from a Gemini surfactant (G_12-8-12). A phosphor, palladium meso-tetra (4-carboxyphenyl) porphyrin (Pd-TCPP) and Al³⁺ ions were loaded within the hybrid system. Interestingly, the room temperature phosphorescence (RTP) of Pd-TCPP can be efficiently enhanced and modulated by the concentration of Al³⁺ ions. The enhancement effect could be attributed to the interactions between Al³⁺ and DBC as well as porphyrin, which verified by ¹H NMR analysis. The study of transmission electron microscopy and scanning electron microscopy indicated that a more compact 3D network structure of the gel system was formed upon the addition of Al³⁺. In addition, measurement of critical micelle concentration indicated that Al³⁺ ions increase the surface activity of G_12-8-12 to promote micelle formation, thereby increasing the dispersion of Pd-TCPP in the hybrid gels. Based on the synergistic effect of these results, the non-radiative transition of Pd-TCPP was efficiently inhibited, resulting in highly efficient RTP. Furthermore, the enhanced RTP of as-prepared gel system shows potential application to detect trace Hg²⁺ ions because the RTP can be quenched by Hg²⁺. A linear relationship between RTP against the logarithmic concentration of Hg²⁺ was found over the range of 6 × 10^-8 and 1 × 10^-6 mol/L. The detection limit was found to be 0.017 nmol/L.

Mass spectrometry as test bench for medicinal chemistry studies

This review describes how mass spectrometry can be used as a powerful test bench to obtain information on the biological activity of target compounds. Considering that mass spectrometry is based on the chemical reactivity of the analytes, it is possible to investigate the stability of the active compounds, to predict their behaviour in the environment of interest, and to obtain structure-reactivity relationships for new molecules of pharmacological interest. Electron ionization and metastable ion studies give evidence of the correlation between the mutagenic properties of a series of aryl and heteroaryl triazenes and mass spectrometric data. A linear relationship between the energetics of C(O)-O bond cleavage of some carbamic acid O-aryl esters and their FAAH inhibition activity has been proved by electrospray-ionization ion-trap mass spectrometry. An inverse correlation between the stability and cytotoxic activity of some copper complexes has been clearly established by electrospray-ionization mass spectrometry. Moreover, because of the sensitivity and specificity of mass spectrometry, it has been possible to determine and characterize impurities that in some cases can be the real bioactive compound.

Pharmacological tools in endocannabinoid neurobiology

Pharmacological and biochemical investigations on the endocannabinoid system are facilitated by the availability of compounds which interact with its constituents in specific and understandable ways. This chapter describes the main representatives of several classes of chemicals employed as pharmacological tools in this field, focusing on small organic compounds having, where possible, a drug-like structure. Many compounds having different intrinsic activity and selectivity towards the G-protein coupled receptors (GPCR) CB₁ and CB₂ are now available and are currently employed in research protocols. Recently, allosteric ligands for CB₁ receptor and selective ligands for GPR55, a newly characterised GPCR, have also been described in the literature. As for compounds affecting endocannabinoid levels in living tissues, many classes of selective and, in some cases, drug-like inhibitors of FAAH are available, while only compounds with poor selectivity or in vivo activity are known to inhibit other enzymes involved in endocannabinoid catabolism, such as NAAA or MGL, and in endocannabinoid biosynthesis.

Therapeutic Potential of Endocannabinoid-Hydrolysing Enzyme Inhibitors

The specific protein target of delta9-tetrahydrocannabinol (delta9-THC), the main active ingredient of Cannabis sativa L., was characterized from rat brain nearly 20 years ago, and several endogenous compounds and proteins comprising the endocannabinoid (eCB) system have since been discovered. It has become evident that the eCB system consists of at least two cannabinoid receptors (i.e. the CB1 and CB2 receptors), in addition to their endogenous ligands (the eCBs) and several enzymes involved in the biosynthesis and catabolism of the eCBs. The two well-established eCBs, N-arachidonoylethanolamide (AEA) and 2-arachidonoylglycerol (2-AG), are produced by neurons on demand, act near their sites of synthesis and are effectively metabolized by fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL), respectively. Inhibitors specifically targeting these enzymes could offer novel therapeutic approaches (e.g. for the treatment of pain and movement disorders). This MiniReview summarizes the literature concerning the potential therapeutic potential of FAAH and MGL inhibitors.